Plans to initiate Phase 2 clinical trial in Adrenocortical Carcinoma in early 2026 through unique partnership between Cytovation, Cancer Research UK and the Norwegian Cancer Society
You might also be interested in reading Tether leads $8 million investment in Speed to push USDT further into everyday payments .